Tag Archives: MetMAb
New Monoclonal Antibodies Increased Survival in Lung Cancer Patients
A new study showed that non-small-cell lung cancer (NSCLC) patients who have high level of Met proteins in their tumor can have their survival increase three-fold by receiving experimental antibody MetMAb in combination with erlotinib (Tarceva). In the trial, 137 previously-treated … Continue reading
Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer
Tagged erlotinib, Met, MetMAb, Monoclonal antibodies, Non small cell lung cancer, NSCLC, progression-free survival, Survival, Tarceva
Comments Off on New Monoclonal Antibodies Increased Survival in Lung Cancer Patients